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DOI: 10.1039/c1sm05686gRecent studies in our laboratories have demonstrated that a helical polypeptide (17H6), equipped with
a histidine tag and a helical alanine-rich, glutamic-acid-containing domain, exhibits pH-responsive
assembly behavior useful in the production of polymorphological nanostructures. In this study, the
histidine tag in these polypeptides was replaced by polyethylene glycol (PEG) with different molecular
masses (5 kDa, or 10 kDa), and the self-association behavior of 17H6 and the PEGylated conjugates
was characterized via dynamic light scattering (DLS), small angle neutron scattering (SANS), and
cryogenic transmission electron microscopy (cryo-TEM). DLS experiments illustrated that the
polypeptide and its PEG-conjugates undergo reversible assembly under acidic conditions, suggesting
that the aggregation state of the polypeptide and the conjugates is controlled by the charged state of the
glutamic acid residues. Nanoscale aggregates were detected at polypeptide/conjugate concentrations as
low as 20 mM (0.3–0.5 mg ml1) at physiological and ambient temperatures. Scattering and
microscopy results showed that the size, the aggregation number, and the morphology of the aggregates
can be tuned by the size and the nature of the hydrophilic tag. This tunable nature of the morphology of
the aggregates, along with their low critical aggregation concentration, suggests that PEG-alanine-rich
polypeptide conjugates may be useful as drug delivery vehicles in which the alanine-rich block serves as
a drug attachment domain.Introduction
The self assembly of amphiphilic block copolymers in solution
has offered a versatile approach to prepare a variety of nano-
structures such as micelles, nanospheres, nanocapsules and
polymersomes.1 The driving force in the formation of these
nanostructures is the differing solubility properties of the sol-
vophilic and solvophobic block(s) in a selective solvent. The lack
of solubility of the solvophobic block(s) drives the self-associa-
tion of those block(s), while the solvophilic block(s) maintain(s)
the dispersion of the self-assembled structure in the solution
phase by acting as a barrier between the solvophobic block(s)
and the solvent.2–4 It is well known that the morphology and size
of the resulting self-assembled structures can be tuned chiefly by
the nature and composition of the blocks and solvent
properties.5–10 Alternatively, solution temperature7,11–15 and
pH,11,14,16 additives,5,6,8,12,16,17 copolymer concentration,7,9 andaDepartment of Materials Science and Engineering, University of
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9758 | Soft Matter, 2011, 7, 9758–9766processing route16–24 have also been reported to change the size
and the morphology of the aggregates.
Owing to the diversity in the manipulation of these structures
as well as their ability to solubilize/stabilize solvophobic mole-
cules, self-assembled block copolymers have been proposed for
and employed in many applications. For example, in the
cosmetics industry, pluronic micelles serve as fragrance delivery
systems.25 Block copolymer aggregates have also been employed
in the synthesis and stabilization of metal oxides26 and inorganic
nanoparticles27 and in fluorescence resonance energy transfer
(FRET) systems.28 Many studies have focused on the application
of block copolymers in drug delivery.29–32 Biocompatible block
copolymers have gained interest in this area as they form non-
toxic scaffolds for insoluble drugs. Additionally, the erosion
properties of biodegradable polymers have also been utilized to
control drug release rates.33,34 In these biocompatible systems,
polyethylene glycol (PEG) has become a common choice for
a hydrophilic block, as it increases plasma half-life of the resul-
tant block copolymer due to the ‘stealthy’ nature of PEG.32,35
Polylactic acid/polylactic-co-glycolic acid,29,33,36 poly-
caprolactone33,37 and polyamino acids38–41 have been common
choices as biodegradable hydrophobic blocks, and/or as blocks
for attachment of hydrophobic drugs. Covalent attachment of
hydrophobic drugs to reactive polyamino acids such as poly-
lysine and polyaspartate renders the polypeptide domain
hydrophobic and reduces burst release of the drug compared to
the simple encapsulation of drug (i.e. through hydrophobicThis journal is ª The Royal Society of Chemistry 2011
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View Article Onlineinteractions). Moreover, the nature of the chemical bond
between the scaffold and the drug can be used to control drug
release rate. In addition, the ability to tune the size of such
complexes (e.g., to sizes <100 nm) is advantageous in applica-
tions including cancer therapy.38,39,42
Despite their inherent biodegradability, facile synthesis, and
modification,43 block copolymers based on genetically engi-
neered polypeptides have not been exploited in the delivery of
hydrophobic drugs as frequently as their synthetic polymer
counterparts. Of the recombinantly derived block copolypep-
tides, elastin-like polypeptides (ELPs) are the most studied
polypeptide as a drug carrier due to their lower critical solution
temperature (LCST)-like behavior. For example, thermosensi-
tive nanoparticles based on diblock ELPs have been prepared as
nanocarrier systems.45 Most of the studies have focused on ELP-
DOX conjugates, which have been shown to be effective tumor-
targeting systems.46–48
We have reported recombinant alanine-rich, glutamic-acid-
containing helical polypeptide scaffolds that can be chemically
modified with saccharides, and have used these scaffolds to
manipulate multivalent interactions.49,50 These polypeptides
comprise both an alanine-rich block and a decahistidine tag;
detailed characterization of a polypeptide with the highest
glutamic acid density (17H6) showed that it exhibits pH-
responsive self-association that can yield nanostructures with
different morphologies. As determined via dynamic light scat-
tering (DLS) investigations, the polypeptide aggregates have
a hydrodynamic radius of 10–20 nm and reversibly dissociate
into monomers upon deprotonation of the glutamic acid resi-
dues.51 In contrast, the polypeptide (in the same concentration
range) in pH 7.4 phosphate-buffered saline (PBS) exhibited
a lack of aggregation, indicated by very low scattering in the
DLS experiment. At pH 7.4, deprotonation of the glutamic
acid residues likely provides charge-charge repulsions that
increase the solubility of the alanine-rich block and prevent
self-association of the polypeptide. We hypothesized that 17H6
acts as an amphiphilic block copolymer comprising the posi-
tively charged histidine tag and the alanine-rich domain that
becomes more hydrophobic upon protonation of glutamic acids
at acidic pH.
In the scope of the present study, we aimed to determine if it
was possible to manipulate the association of the polypeptide
domain via the conjugation of hydrophilic polymers of various
molecular masses. Accordingly, the histidine tag of the poly-
peptide was cleaved and replaced by PEG blocks (with molecular
masses of 5 kDa or 10 kDa) and the self-association behavior of
the polypeptide and the PEG-modified polypeptides (PEG5K-
c17H6 and PEG10K-c17H6) was investigated. The sequencesTable 1 Sequences and molecular masses of the polypeptides and the conju
Notation Sequence
17H6 MGH10SSGHIHM(AAAQEAAAAQ
c17H6 (AAAQEAAAAQAAAQAEAAQAA
PEG5K-c17H6 (mPEG5K)-(AAAQEAAAAQAAAQ
PEG10K-c17H6 (mPEG10K)-(AAAQEAAAAQAAA
a Reaction of cyanogen bromide with methionine yields a mixture of homose
This journal is ª The Royal Society of Chemistry 2011and the molecular masses of the polypeptides and the conjugates
are given in Table 1. The nanostructures of 17H6 and the
conjugates under acidic conditions were characterized via
dynamic light scattering, small angle neutron scattering, and
cryogenic transmission electron microscopy. Our results illus-
trate basic principles for manipulating aggregate structures with
variations in copolymer composition. The outcomes of this study
have potential use in the development of polypeptide-based drug
carrier systems.
Experimental
Materials
The polypeptide 17H6 with a sequence given in Table 1 was
expressed using BL21(DE3)pLysS type E. coli expression host,
and purified using nickel-nitrilotriacetic acid (Ni-NTA) affinity
chromatography as described elsewhere.49,52 The histidine tag of
17H6 was cleaved by the reaction with cyanogen bromide
(CNBr) to yield the cleaved polypeptide, c17H6 (Table 1). Pro-
pionaldehyde-functionalized PEG (5 kDa or 10 kDa) was
conjugated to the N-terminus of c17H6 via Schiff base formation
and subsequent reduction. A simplified route for the conjugate
synthesis is given in Fig. S1 in the ESI.† The conjugates were
purified using anion exchange chromatography followed by
size exclusion chromatography. The synthesis of the
monoPEGylated conjugates was confirmed by gel permeation
chromatography (GPC) and matrix-assisted laser desorption/
ionisation-time of flight (MALDI-TOF) mass spectroscopy,
givenwith the details of synthesis and purification protocols in Top
et al. 2011.53Phosphate buffer at pH2.3was prepared using 10mM
o-phosphoric acid (Fisher) with salt (140 mM sodium chloride
(NaCl) and 10 mM potassium chloride (KCl) (Fisher)). Phosphate
buffered saline (PBS) at pH7.4, containing the sameNaCl andKCl
concentrations as pH 2.3 buffer, was prepared using a dry-blend
buffer pack (Thermo Scientific Inc. (Rockford, IL)).
Dynamic light scattering
Dynamic light scattering (DLS) experiments were carried out
using a BI9000AT autocorrelator and a BI200SM goniometer
(Brookhaven Instruments Corp., Holtsville, NY) at 532 nm.
Samples were prepared by direct dissolution in the appropriate
buffer followed by filtration with a 0.22 mmMillex syringe-driven
filter unit (Millipore, Bedford, MA). Concentrations of the
samples were confirmed by UVmeasurements and were based on
a calibration curve constructed from samples with concentra-
tions accurately determined via amino acid analysis. For the
estimation of the apparent hydrodynamic diameter values,gates
M (kDa)
AAAQAEAAQAAQ)6AGGYGGMG 14.8
Q)6AGGYGGS/S-lactone
a 12.4
AEAAQAAQ)6AGGYGGS/S-lactone 17.4
QAEAAQAAQ)6AGGYGGS/S-lactone 22.4
rine and homoserine lactone.44
Soft Matter, 2011, 7, 9758–9766 | 9759
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View Article Onlinesamples were prepared in 10 mM phosphate buffer including salt
(140 mM NaCl and 10 mM KCl) at pH 2.3. Correlation func-
tions were recorded at multiple angles and at 20 C and 37 C
after equilibrating the sample for at least 15 min at the appro-
priate temperature. Average diffusion coefficients (D) and
polydispersity-index values were estimated using a second-order
cumulant fit of the time correlation of the scattering decay, with
apparent hydrodynamic diameter values calculated from (D)
using the Stokes–Einstein equation. Further details of the anal-
ysis are described elsewhere.51 In the pH responsiveness
measurements, a 50 mM sample was prepared in phosphate-
buffered saline (PBS) at pH 7.4, and the average scattering
intensity was recorded. Then, the pH of the solution was adjusted
to 2.3 using concentrated HCl, the solution was filtered and
scattering intensity was measured again. Two more intensity
measurements were taken after adjusting the solution pH to 7.4
with concentrated NaOH, followed by readjustment of the
solution pH to 2.3. In each pH adjustment cycle a few to several
ml of acid or base solution was added to 1 ml solution to
minimize dilution effects.Small angle neutron scattering
Small angle neutron scattering (SANS) experiments were carried
out using 30 m instruments, NG3 or NG7, at the NIST Center
for Neutron Research (NCNR), National Institute of Standards
and Technology (NIST), Gaithersburg, MD. Samples were
prepared in D2O- containing buffers to ensure the contrast
between the H-rich samples and D2O and to minimize incoherent
scattering. 1 or 2 mm pathlength, demountable titanium cells
were used, and the temperature of the cells was controlled using
a 10CB 10-position sample holder with a NESLAB circulating
bath. Neutrons at l ¼ 6 A (with a wavelength spread, Dl/l, of
0.14) were employed in the scattering experiments. Data acqui-
sition was performed using a 64 cm 64 cm 2-D detector at three
different instrument configurations: 1, 4, and 13 m detector
distances (with focusing lenses at 13 m only). The data were
reduced using Igor Pro software (WaveMetrics, Lake Oswego,
OR) with the SANS Reduction v5 macro developed at the
NCNR.54Fig. 1 Comparison of average laser light scattering intensity of PEG5K-
c17H6 as a function of pH.Cryogenic transmission electron microscopy
Cryogenic transmission electron microscopy (cryo-TEM)
observations of the samples were performed at 120 kV using
a Tecnai 12 microscope with a Gatan cryo-holder system (FEI
Inc., Hillsboro, OR). A 100 mM sample was prepared in the
phosphate buffer, including salt at pH 2.3 as described above.
Approximately 5 mL of sample was applied on a lacey carbon
film coated on a copper grid in a Vitrobot vitrification system
(FEI Inc., Hillsboro, OR). After blotting and plunging of the
specimen in liquid ethane, the vitrified sample was transferred to
the cryoholder in a cryo-transfer stage immersed in liquid
nitrogen. The cryoholder temperature was maintained below
170 C to prevent sublimation of vitreous water during
imaging. The dimensions of the aggregates were determined
using ImageJ55 (U.S. National Institutes of Health, Bethesda,
MD) by taking the average of 20 measurements.9760 | Soft Matter, 2011, 7, 9758–9766Results and discussion
pH-responsive assembly
The pH responsiveness of PEG5K-c17H6 was tested by
measuring the average intensity of 532 nm laser light scattering
(90 scattering angle); representative results are shown in Fig. 1.
Initially, in PBS buffer at pH 7.4 (above the pKa of Glu), the
scattering intensity from 50 mM polypeptide solution of the
conjugate is low (similar to the value of scattering intensity of
the buffer) but upon a reduction in pH (below the pKa of Glu) the
scattering intensity increased markedly suggesting the formation
of aggregates; this aggregation is suggested to be reversible based
on the observation of similar scattering results with repeated
variations of solution pH (Fig. 1). These data indicate that the
PEG conjugate retains the pH responsiveness observed for 17H6
alone,51 corroborating the supposition that self-assembly is
controlled by the ionization state of the glutamic acid residues.
Average diffusion coefficients and polydispersity index (PDI)
values of the aggregates were determined using a second order
cumulant fit of the DLS data. Representative fits for PEG5K-
c17H6 and PEG10K-c17H6 (100 mM on a monomer basis) at
20 C, in the pH 2.3 buffer containing isotonic salt, are given
Fig. S2 and S4 (ESI†), respectively, and indicated good agree-
ment between the experimental data and the cumulant fits; the
residuals of the fits were small and randomly scattered (data not
shown) confirming the validity of the fit. PDI values ranged
between 0.1 and 0.3; no correlation was observed between PDI
and temperature or concentration or nature of the block copoly-
mer. Diffusion coefficients were estimated from the slope of the
plots of decay rate versus the square of the scattering vector (G vs.
q2; Fig S3 and S5, ESI†). G vs. q2 was linear with an intercept of
zero (within statistical uncertainty) for all sample conditions,
consistent with an isotropic aggregate morphology and lack of
contributions to G from rotational diffusion.56 Hydrodynamic
diameter (DH) values of the polypeptide and the conjugates wereThis journal is ª The Royal Society of Chemistry 2011
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View Article Onlineobtained from the fitted diffusion coefficients at sample
concentrations of 20, 50 and 100 mM, at 20 C and 37 C; results
are shown in Fig. 2a and Fig. 2b, respectively. Similar hydro-
dynamic diameter values (20–30 nm, Fig. 2a) were obtained for
17H6 and the conjugates with little or negligible dependence on
polypeptide concentration as observed in other block copolymer
systems57,58 over select concentration ranges. DH values at 37
C,
ranging between 25 and 40 nm (Fig. 2b), were observed to be
slightly larger than those at 20 C.
Various trends have been observed for other block copolymer
systems, depending on the chemical nature of the copolymers.
For a polystyrene-block-poly(N-vinylpyrrolidone) (PS-PNVP)
block copolymer, for example, no change in DH was observed
between 10 and 40 C.57 A decrease in DH with T was obtained
for thermosensitive poly(2-cinnamoylethyl methacrylate)-block-
poly(N-isopropylacrylamide) (PCEMA-PNIPAAm) due to the
collapse of PNIPAAm.7 Similarly, a significant decrease in DH
was observed upon increasing temperature for polystyrene-
block-poly(ethylene oxide) (PS-PEO) copolymers due to the
morphological change from vesicles to worm like micelles.13
However, c17H6 is likely more flexible compared to thoseFig. 2 Concentration dependence of hydrodynamic diameters of 17H6
(circles), PEG5K-c17H6 (squares), and PEG10K-c17H6 (triangles) in pH
2.3 buffer containing isotonic salt at (a) 20 C (open symbols), and (b)
37 C (closed symbols).
This journal is ª The Royal Society of Chemistry 2011core-forming polymers, which may allow chain exchange so that
aggregate size can vary with temperature. Morphological
changes or expansion of corona chains may be another expla-
nation of the temperature dependence of DH for the alanine-rich
copolymers. Indeed, it has been shown that the apparent volume
of PEG chains increases with increasing temperature, due to
disordering of tightly bound water.58 Regardless of the detailed
reasons for these modest differences as a consequence of changes
in temperature, our results show that the protonated alanine-rich
blocks support the formation of nano-size aggregates as long as
a hydrophilic block is attached. The pH dependence of the self-
association of the polypeptide and the conjugates indicates that
they can form stable aggregates when the repulsions between the
glutamic acids are eliminated. Hence, attachment of hydro-
phobic drugs to the glutamic acid residues should drive aggre-
gation of the polypeptide/conjugates independent of pH. These
aggregates form at relatively low concentrations (as low as 20 mM
(0.3–0.5 mg ml1)) and maintain their integrity at physiological
temperatures, suggesting that these association processes may be
relevant to the assembly of drug delivery vehicles.SANS analysis of aggregates
Preliminary investigations with SANS were used to evaluate
structural parameters such as the radius of gyration, morphology
and aggregation number of the aggregates. SANS data were
collected at 100 mM sample concentrations so as to maximize
scattering intensities (see also below), and the samples were
prepared in phosphate buffer containing 150 mM salt at acidic
pD (below the pKa of Glu) in D2O. Since the actual scattering
intensities of the samples are low, incoherent scattering becomes
considerable. For this reason, the intensity of the background
scattering (B) was subtracted from the actual scattering intensi-
ties (I) to obtain coherent scattering intensities (Ic) and in all data
analyses (Debye and Kratky plots and power law analyses)
coherent scattering intensity values were used.59 SANS curves for
17H6 and the conjugates (with background scattering correction)
at 20 C, and 37 C are given in Fig. 3. Radius of gyration values
and scattering intensity values at q ¼ 0 were determined using
a Debye plot, which has been used in the analysis of surfactant
and copolymer aggregates.60,61 For q < 0.01, the Debye equation
can be given as:
IcðqÞ ¼ I0 2ðe
x  1þ xÞ
x2
(1)
where x ¼ (qRg)2, I0 is the scattering intensity at q ¼ 0, and Rg is
the radius of gyration.60 Debye plots of the samples are given in
Fig. 4 and estimated I0 and Rg values are given in Table 2. Rg
values were estimated to be 14–28 nm ranging as a function of
the nature of the hydrophilic block and temperature. Rg/RH
values (characteristic ratios) were used to estimate the architec-
ture of the aggregates and are given in Table 2. It is commonly
accepted that characteristic ratio values of 0.778, 1.505, and >2
indicate hard spheres, structures with a random-coil organiza-
tion like that of Gaussian chains, and rigid rods respectively.62,63
Comparisons of these values with the characteristic values
determined for the polypeptide and conjugates at room
temperature (Table 2) yield insights into the structures formed
by the aggregation of these macromolecules. 17H6 andSoft Matter, 2011, 7, 9758–9766 | 9761
Fig. 3 SANS curves of 17H6 (circles), PEG5K-c17H6 (squares), and
PEG10K-c17H6 (triangles) in pH 2.3 buffer at (a) 20 C (open symbols),
and (b) 37 C (dotted symbols).
Fig. 4 Debye plots of 17H6 (circles), PEG5K-c17H6 (squares), and
PEG10K-c17H6 (triangles) in pH 2.3 buffer at (a) 20 C (open symbols),
and (b) 37 C (closed symbols). Debye fits are given as lines.
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View Article OnlinePEG5K-c17H6, with characteristic ratios of approximately 1.8
and 1.9, respectively, are suggested to adopt semi-flexible elon-
gated structures. In contrast, PEG10K-c17H6, with a character-
istic ratio near 1, is suggested to form spherical structures; these
results are consistent with what is anticipated based on the
increasing length of the hydrophilic block presumably biasing
towards greater surface curvature for the aggregates. The Rg/RH
values for all polypeptides decrease near physiological tempera-
ture, suggesting that both the polypeptide and the conjugates
form more spherical structures. Temperature-induced structural
changes, from elongated structures to spheres, have also been
observed for other block copolymer systems such as PS-PEO,13
and polystyrene-block-polyisoprene (PS-PI)64 micelles. The
morphological change in the PS-PI systems was attributed to the
increase in excluded volume parameter of PI and the decrease in
the surface free energy for PS in heptane as temperature
increases.64 Thus, it can be speculated that any temperature-
induced structural changes of the conjugates may be due to the
increase in the volume of PEG chains upon increasing
temperature58.
I0 values obtained from the Debye plots were used to estimate
aggregation number, <y>, using the following equation:9762 | Soft Matter, 2011, 7, 9758–9766\y. ¼ Magg
Mmon
¼ I0NA
cðr rsÞ2y2Mmon
(2)
where Magg and Mmon are the molecular weight of aggregate
and unimer respectively, NA is Avogadro’s number, c is the
concentration of solute, r and rs are the scattering length
density of solute and solvent respectively, and n is the partial
molar volume of solute.59 In the estimation of <y> values, r
and n of the conjugates were calculated based on the weight
fraction of each block (nc17H6 ¼ n17H6 ¼ 0.71 cm3 g1, nPEG ¼
0.89 cm3 g1, rc17H6 ¼ 1.99  1010 cm2, r17H6 ¼ 2.16 
1010 cm2, rPEG ¼ 0.64  1010 cm2). Calculated <y> values are
given in Table 2. Aggregation numbers were estimated to be in
the order of 102 and 101 for the polypeptide and the
conjugates, respectively, consistent with the relative RH and Rg
values in Table 2. An approximate 35% drop in aggregation
number for the 17H6, upon increasing temperature, was indi-
cated from the SANS data despite similarities in the overall
shape of the scattering curve, suggesting some limitations in
determining the aggregation number for 17H6 from these data.
The estimated high aggregation number (102) of the poly-
peptide thus may result in part from overestimated I0 valuesThis journal is ª The Royal Society of Chemistry 2011
Table 2 Summary of DLS and SANS data
Sample T (C) RH (nm) Rg (nm) Rg/RH I0 <y>
17H6 20 15.5  0.2 27.6  0.3 1.78  0.03 8.34  0.09 266  3
17H6 38  1a 19.2  0.1 22.1  0.3 1.15  0.02 5.36  0.06 171  2
PEG5K-c17H6 20 11.1  0.2 20.9  0.7 1.88  0.08 2.01  0.05 31  1
PEG5K-c17H6 38  1a 14.1  0.3 19.1  0.6 1.35  0.06 2.16  0.05 33  1
PEG10K-c17H6 20 13.0  0.8 14.1  0.4 1.08  0.06 1.74  0.03 14  1
PEG10K-c17H6 37 16.9  0.1 14.2  0.3 0.84  0.02 1.88  0.03 15  1
a Average of SANS experiment temperature (39 C) and DLS experiments’ temperature (37 C).
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View Article Onlinethat result from the lack of a plateau in the low q regime. No
such limitations were suggested in the data for the conjugates.
Despite the ambiguities in quantitatively estimating aggregate
numbers from the 17H6 data, it is clear from the data that the
polypeptide exhibits a higher I0 value, which unambiguously
indicates a higher average aggregation number. The decrease in
the aggregation number with the increase in the degree of the
polymerization of the solvophilic chain (NB) was expected,
given the increase in steric bulk of the larger PEG chains,
which favors an increase in surface curvature. The grafting
distance, b, (i.e., the square root of the area per chain (b2),
which is comparable to the area per head group in the case of
surfactant micelles) increases with increasing degree of poly-
merization of the solvophilic chain, with resulting morpholo-
gical changes as observed for PS-PEO65 and poly(butylene
oxide-block-poly(ethylene oxide) (PBO-PEO)66 copolymers.
Kratky plots were also used to assess the structure of the
aggregates and are given in Fig. 5. For 17H6 and PEG5K-c17H6,
a definite peak was obtained. In contrast, PEG10K-c17H6
exhibited a slight peak and reached a horizontal asymptote at
increasing q values. The peak in a Kratky plot suggests
a compact structure due to strong core contrast67 as observed in
folded proteins,68,69 star polymers,70,71 and micellar systems.61,67,72
Horizontal asymptotes (e.g., Ic  q2 scaling behavior at high q)
have also been observed for polymer coils and micelles,61 star
polymers70 and polymer brushes surrounding lamellar sheets73
and in these previous cases is due to the scattering from corona
chains.74 Our results thus indicate scaling for 17H6 and PEG5K-
c17H6 that is consistent with that of compact structures, while
that for PEG10K-c17H6 reveals a more dominant effect of
swollen PEG chains, as expected. Kratky plots of the samples at
a near physiological temperature are given in Fig. S6 (ESI†) and
are similar to those in Fig. 5, showing no significant temperature
effect.
Aggregate compactness was also roughly indicated from the
slopes of log Ic vs. log q curves in the intermediate and high q
regions (Fig. S7, ESI†). Of note in Fig. S7 is the existence of
a slope of approximately 4 for 17H6 (Fig. S7a), describing the
Porod region (scattering from a sharp interface) and corrobo-
rating the compact structure for 17H6 aggregates indicated by
the Kratky plots. Scattering from PEG5K-c17H6 and PEG10K-
c17H6 structures (Fig. S7b and S7c), in contrast, lacked a Porod
region (Fig. S7b) likely due to the lack of a sharp interface caused
by the dispersion of the PEG chains in the water phase.74 Thus,
Kratky plots and power law plots indicated that the aggregates
compactness is regulated by the nature and the length of the
hydrophilic block.This journal is ª The Royal Society of Chemistry 2011Morphology
The morphologies of the aggregates were more directly visualized
via cryo-TEM. Images of the aggregates are shown in Fig. 6, and
the dimensions of the aggregates, estimated from the TEM data,
are presented in Table 3. As it is clearly illustrated in Fig. 6a, the
polypeptide 17H6 adopts irregular and elongated aggregates, as
might be expected for this moderately hydrophobic polypeptide.
17H6 tends to form clusters under these conditions, perhaps due
to the increase in local concentration during TEM sample
preparation.75 In contrast to the elongated structures observed
for 17H6 in cryo-TEM, globular structures were obtained when
employing a negative-staining technique,51 likely as a result of
changes in morphology during drying of these aggregation-prone
polypeptides.
Striking differences in morphology, however, are observed
upon the addition of PEG chains to the cleaved polypeptide. As
clearly captured in Fig. 6b, PEG5K-c17H6 adopts regular and
elongated structures, corroborating the estimations based on
Rg/RH values. A fraction of PEG5K-c17H6 structures in the
images appears spherical; these structures are likely the cross-
section of the elongated structures when they lie perpendicular to
the surface. The observed core widths of these elongated struc-
tures of 17H6 and PEG5K-c17H6 are not different from each
other, but longer structures were observed for the polypeptide as
expected from the relative Rg and RH values of the polypeptide
and PEG5K-c17H6. These observations clearly show the stabi-
lization of the smaller structures imparted by the PEG corona,
and suggest opportunities to vary the morphologies of these
aggregates via variations in the PEG chain length. Indeed, as
illustrated in Fig. 6c, PEG10K-c17H6 exhibits a different
morphology; spherical structures with an average core diameter
of 19 nm, and a polydispersity greater than that of PEG5K-
c17H6, are observed. Considering the Rg of PEG10K (3 nm),
this value is consistent with the DH estimates obtained from DLS
(26 nm) within experimental uncertainty, as solvated PEG
chains are not likely to appear in cryo-TEM observations.76
The cylinder-to-sphere transformation as hydrophilic block
length increases is consistent with experimental observations of
other polymeric systems,77,78 and predictions based on molecular
dynamics simulations.79 An unexpected result is the10 nm core
width of PEG5K-c17H6 versus the 20 nm core diameter of
PEG10K-c17H6, given experimental observations and scaling
relationships that predict that core diameter is inversely
proportional to solvophilic chain length.5,78,80 It seems likely that
PEG10K-c17H6 has a more swollen core, owing to a lower
efficiency of packing of the polypeptide chains in the sphericalSoft Matter, 2011, 7, 9758–9766 | 9763
Fig. 5 Kratky plots of (a) 17H6, (b) PEG5K-c17H6, and (c) PEG10K-
c17H6 at 20 C.
Fig. 6 Cryo-TEM images of (a) 17H6, (b) PEG5K-c17H6, and (c)
PEG10K-c17H6. Scale bars: (a), (b) 100 nm, and (c) 200 nm.
Pu
bl
ish
ed
 o
n 
30
 A
ug
us
t 2
01
1.
 D
ow
nl
oa
de
d 
by
 Iz
m
ir 
Y
uk
se
k 
Te
kn
ol
oji
 on
 28
/02
/20
17
 15
:05
:29
. 
View Article Onlineaggregates; the lower aggregation number obtained for these
structures is consistent with these speculations. Additionally, in
contrast to many examples of block copolymers composed of one
type of monomer in each block, the hydrophobic c17H6 block in
our polymers contains different monomers—hydrophobic
alanine as well as hydrophilic glutamine and glutamic acids—and
it is possible that these hydrophilic components within the core9764 | Soft Matter, 2011, 7, 9758–9766 This journal is ª The Royal Society of Chemistry 2011
Table 3 Dimensions of the aggregates from cryo-TEM data
Sample Core dimension Average size (nm)
17H6 width 10  2
17H6 length 52  10
PEG5K-c17H6 width 7  2
PEG5K-c17H6 length 35  4
PEG10K-c17H6 diameter 19  6
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View Article Onlineblocks may be differently hydrated in aggregate structures of
different morphologies.Conclusions
The self-association behavior of a polypeptide, 17H6, containing
a histidine-rich fusion tag and an alanine-rich block, was
compared to the self-association of PEGylated conjugates of the
alanine-rich polypeptide. The alanine-rich block, equipped with
ionizable amino acids, imparts pH responsiveness to 17H6 and
the conjugates. It was also shown that the histidine tag plays
a solubilizing role when it is charged, in addition to its conven-
tional function in protein purification and its observed role in the
immobilization of negatively charged nanoparticles.81 At acidic
pH (upon protonation of glutamic acid residues), the polypeptide
and the conjugates formed aggregates with elongated or spher-
ical morphologies depending on the nature and length of the
hydrophilic block. Although only a few examples were shown in
this study, our results clearly illustrate that a combination of
recombinant synthesis and chemical conjugation methods may
offer a wide spectrum of nanostructures with controlled size and
morphology by the precise control of the block composition.
The pH-responsiveness observed in the c17H6 based polymer
systems suggests opportunities for these systems in drug delivery
applications. Specifically, functionalization of the reactive glu-
tamic acids with hydrophobic molecules is likely to trigger the
aggregation of the alanine-rich block, but independent of pH.
Owing to the low concentrations at which the polypeptide and
conjugates aggregate (aggregation concentrations lower than
0.5 mg ml1 at both ambient and physiological temperatures),
coupled with the tuning of their morphologies, PEG-c17H6
conjugates may be useful as drug carrier systems where c17H6
serves as a hydrophobic drug attachment site (similar to PEG-
polyaspartate-drug conjugate systems38,39,42), or where the poly-
peptide domain serves as a therapeutic molecule based on its
multivalent display of ligands or drugs.Acknowledgements
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